NSC 352122

Known as: NSC-352122 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1986-2006
0119862006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
1989
1989
Trimetrexate glucuronate (TMTX), a non-classic folate antagonist, has been evaluated clinically on several schedules. We studied… (More)
  • table 2
  • table 3
  • table 4
  • table 5
  • figure 1
Is this relevant?
1989
1989
Trimetrexate (TMTX) is a potent inhibitor of dihydrofolate reductase that circumvents the transport resistance seen with… (More)
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1988
1988
Trimetrexate (TMQ; NSC 352122) is a potent inhibitor of dihydrofolate reductase with good activity against murine i.p.-implanted… (More)
Is this relevant?
1987
1987
The disposition of the methotrexate analogue trimetrexate (TMTX, NSC 352122; 2,4-diammino-5-methyl-6-[(3,4,5-trimethoxyanilino… (More)
Is this relevant?
1986
1986
The pharmacokinetics of trimetrexate was studied in Rhesus monkeys following i.v. bolus, continuous i.v. infusion, oral, and… (More)
  • table 1
  • table 2
Is this relevant?